市場調査レポート
商品コード
1223947

世界の感染監視ソリューション市場:ソフトウェア別 (オンプレミス、Webベース)・サービス別 (製品サポート・保守、実装、トレーニング・コンサルティング)・エンドユーザー別 (病院、長期介護施設)・地域別の将来予測 (2027年まで)

Infection Surveillance Solutions Market by Software (On-Premise, Web-Based), Services (Product Support & Maintenance, Implementation, Training & Consulting), End User (Hospitals, Long-Term Care Facilities), and Region- Global Forecast to 2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 258 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
世界の感染監視ソリューション市場:ソフトウェア別 (オンプレミス、Webベース)・サービス別 (製品サポート・保守、実装、トレーニング・コンサルティング)・エンドユーザー別 (病院、長期介護施設)・地域別の将来予測 (2027年まで)
出版日: 2023年02月15日
発行: MarketsandMarkets
ページ情報: 英文 258 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の感染監視ソリューションの市場規模は、2022年の5億7,700万米ドルから、2027年には11億米ドルまで達し、予測期間中に13.8%のCAGRで成長すると予測されています。

この市場は、院内感染の拡大や外科手術の増加、医療費の増加などの要因に伴う需要増加により、有望な成長可能性を有しています。しかし、熟練した医療IT専門家の不足やデータセキュリティの懸念が、この市場の成長をある程度制限すると予想されます。

サービスの種類別では、トレーニング・コンサルティングサービスが最も急速に成長すると見込まれています。大手・中堅企業の多くは、感染監視ソフトウェアを使用する病院などに対して積極的に技術支援を行っています。

組織規模別では、大規模病院 (病床数450床以上) が予測期間中に最大の市場になると予想されます。

地域別に見ると、欧州が予測期間中に2番目に大きなシェアを占める見通しです。

当レポートでは、世界の感染監視ソリューションの市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、製品/サービス別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場の課題

第6章 業界動向

  • イントロダクション
  • 業界動向
  • 規制分析
  • 技術分析
  • エコシステム分析
  • 特許分析
  • 不況の影響

第7章 感染監視ソリューション市場:製品/サービス別

  • イントロダクション
  • ソフトウェア
    • オンプレミスソフトウェア
    • Webベースソフトウェア
  • サービス
    • 製品サポート・保守サービス
    • トレーニング・コンサルティングサービス
    • 実装サービス

第8章 感染監視ソリューション市場:エンドユーザー別

  • イントロダクション
  • 病院
    • 大病院
    • 中規模病院
    • 小規模病院
  • 長期介護施設
    • 老人ホーム
    • 高度看護施設
    • 生活支援施設
  • その他のエンドユーザー

第9章 地域別の感染監視ソリューション市場

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • スイス
    • オランダ
    • 他の欧州諸国
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア・ニュージーランド
    • 韓国
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 革新的なソリューションの採用動向
  • 収益分配分析
  • 市場シェア分析
  • 競合ベンチマーキング
  • 企業評価クアドラント (2021年)
  • スタートアップ/中小企業向けの企業評価クアドラント (2021年)
  • 競合シナリオ
    • 製品/サービスの発売/機能強化
    • 資本取引
    • その他の動向

第11章 企業プロファイル

  • 主要企業
    • BECTON, DICKINSON AND COMPANY
    • CERNER CORPORATION
    • PREMIER, INC.
    • BAXTER INTERNATIONAL INC.
    • WOLTERS KLUWER N.V.
    • MERATIVE
    • ECOLAB
    • BIOMERIEUX SA
    • GOJO INDUSTRIES, INC.
    • RLDATIX
    • VIGILANZ CORPORATION
    • DEB GROUP LTD
    • CLINISYS
    • BIOVIGIL HEALTHCARE SYSTEMS
    • VECNA TECHNOLOGIES
    • HARRIS HEALTHCARE
    • PERAHEALTH
    • MEDEXTER HEALTHCARE
    • CENTRAK
    • CKM HEALTHCARE INCORPORATED
  • その他の企業
    • ASOLVA INC.
    • POINTCLICKCARE
    • VITALACY INC.
    • STANLEY HEALTHCARE
    • VIZZIA TECHNOLOGIES

第12章 付録

目次
Product Code: HIT 4380

The infection surveillance solutions market is anticipated to grow from an estimated USD 577 million in 2022 to USD 1,100 million in 2027, at a CAGR of 13.8% during the forecast period. The market has a promising growth potential due to increased demand the increasing prevalence of hospital-acquired infections, increasing surgical procedures, and rising healthcare expenditure among other factors. However, the Shortage of skilled healthcare IT professionals and Data security concerns are expected to limit the growth of this market to a certain extent.

"Training & Consulting Services: The fastest-growing segment of the infection surveillance services market, by type"

Training & consulting services are expected to witness the fastest growth in the infection surveillance services market during the forecast. Training and consulting services increase healthcare providers' awareness of the latest infection surveillance solutions available in the market. Most large and mid-size companies actively provide technical assistance to hospitals, independent laboratories, and physician office laboratories that use infection surveillance software. Factors such as the increasing importance of value-based care, technological advancements, and growing consolidation in healthcare are driving the market for consulting services.

"The large hospitals is anticipated to be the largest infection surveillance solutions market for hospitals, by type, during the forecast period"

Based on type (the number of beds), hospitals are segmented into large (>450 beds), medium-sized (250-449 beds), and small (<249 beds) hospitals. The large hospitals segment accounted for the largest share of the infection surveillance solutions market for hospitals. The rising number of private hospitals in China and other developing countries is expected to drive the demand for technologically advanced HCIT solutions deployed in ICUs and other departments of hospitals. Furthermore, the complexity of managing HAIs rises with the size of hospitals, as more patients need to be monitored continuously; this is the primary reason for the large share of this end-user segment.

"Europe accounted for the second-largest share in the infection surveillance solutions market during the forecast period"

Europe accounted for the second-largest share of the infection surveillance solutions market during the forecast period. Growth in the European market can be attributed to the increasing adoption of HCIT solutions, the increasing incidence of HAIs, the increasing number of surgeries, and the rising geriatric population. The increasing need to improve patient outcomes has contributed to the adoption of infection surveillance solutions across the region. Several policies and guidelines have been implemented in Europe as infection prevention strategies for hospitals and long-term care facilities which are propelling the demand for infection surveillance solutions in the region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-40%, Tier 2-35%, and Tier 3-25%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-45%, Europe-30%, Asia Pacific-20%, Latin America- 3%, Middle East and Africa-2%

Key players in the Infection Surveillance Solutions Market

The key players operating in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US).

Research Coverage:

The report analyzes the infection surveillance solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product & service, end user, and region. The report also includes a product portfolio matrix of various infection surveillance solutions products & services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection surveillance solutions market. The report analyzes this market by product & service and end user.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection surveillance solutions market
  • Market Development: Comprehensive information on the lucrative emerging markets by products & services and end user
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global infection surveillance solutions market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global infection surveillance solutions market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SEGMENTATION
    • FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key insights from primary experts
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET
    • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 9 CAGR PROJECTIONS
    • FIGURE 10 TOP-DOWN APPROACH
  • 2.4 DATA TRIANGULATION APPROACH
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT, 2021

4 PREMIUM INSIGHTS

  • 4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW
    • FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY END USER AND COUNTRY
    • FIGURE 18 HOSPITALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2021
  • 4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 CHINA TO REGISTER HIGHEST REVENUE GROWTH FROM 2022 TO 2027
  • 4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2020-2027)
    • FIGURE 20 NORTH AMERICA TO DOMINATE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING FORECAST PERIOD
  • 4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing prevalence of hospital-acquired infections
      • 5.2.1.2 Increasing adoption of antimicrobial stewardship programs
      • 5.2.1.3 Increasing number of surgeries
    • TABLE 4 US: PERCENTAGE INCREASE IN SURGICAL VOLUMES
      • 5.2.1.4 Growing geriatric population and increasing incidence of chronic diseases
      • 5.2.1.5 Growing investments to improve healthcare systems
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 High cost of deployment for small healthcare organizations
    • TABLE 5 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2021
      • 5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Increasing consolidation in healthcare industry
      • 5.2.3.2 Cloud-based software solutions
      • 5.2.3.3 Emerging markets
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Shortage of skilled healthcare IT professionals
      • 5.2.4.2 Data security concerns

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS
    • 6.2.2 AI-POWERED SURVEILLANCE SOFTWARE
    • 6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES
    • 6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS
  • 6.3 REGULATORY ANALYSIS
    • 6.3.1 NORTH AMERICA
    • TABLE 6 NORTH AMERICA: REGULATIONS AND LAWS
    • 6.3.2 EUROPE
    • TABLE 7 EUROPE: REGULATIONS AND LAWS
    • 6.3.3 ASIA
    • TABLE 8 ASIA: REGULATIONS AND LAWS
    • 6.3.4 MIDDLE EAST & AFRICA
    • TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS AND LAWS
    • 6.3.5 LATIN AMERICA
    • TABLE 10 LATIN AMERICA: REGULATIONS AND LAWS
    • TABLE 11 KEY GLOBAL REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS
  • 6.4 TECHNOLOGY ANALYSIS
    • 6.4.1 CLOUD COMPUTING TECHNOLOGY
    • 6.4.2 ARTIFICIAL INTELLIGENCE
    • TABLE 12 AI IN HEALTHCARE MARKET, BY REGION, 2017-2020 (USD MILLION)
    • TABLE 13 AI IN HEALTHCARE MARKET, BY REGION, 2021-2027 (USD MILLION)
    • 6.4.3 BLUETOOTH LOW-ENERGY SENSORS
  • 6.5 ECOSYSTEM ANALYSIS
    • FIGURE 22 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS
    • FIGURE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
  • 6.6 PATENT ANALYSIS
    • 6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS
    • FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2012-JANUARY 2023)
    • 6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 25 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012- JANUARY 2023)
    • FIGURE 26 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2012-JANUARY 2023)
    • TABLE 14 INFECTION SURVEILLANCE SOLUTIONS: LIST OF PATENTS/PATENT APPLICATIONS, 2020-2022
  • 6.7 IMPACT OF RECESSION

7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
    • TABLE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
  • 7.2 SOFTWARE
    • TABLE 16 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 17 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.1 ON-PREMISE SOFTWARE
      • 7.2.1.1 Data protection and in-house access to HCIT solutions to drive market
    • TABLE 18 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
    • TABLE 19 ON-PREMISE SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.2.2 WEB-BASED SOFTWARE
      • 7.2.2.1 Increasing demand for data centralization and cost-benefits of solutions to drive adoption
    • TABLE 20 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 21 WEB-BASED SOFTWARE MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 SERVICES
    • TABLE 22 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 23 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.1 PRODUCT SUPPORT & MAINTENANCE SERVICES
      • 7.3.1.1 Rising reliance on outsourcing HCIT support to boost demand
    • TABLE 24 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.2 TRAINING & CONSULTING SERVICES
      • 7.3.2.1 Need to develop IT infrastructure and demand for expert assistance to offer growth opportunities
    • TABLE 25 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 7.3.3 IMPLEMENTATION SERVICES
      • 7.3.3.1 Focus on ensuring regulatory compliance among end users to boost service sector growth
    • TABLE 26 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 HOSPITALS
    • TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.1 LARGE HOSPITALS
      • 8.2.1.1 Growing need to deploy cloud-based solutions to drive growth
    • TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.2 MEDIUM-SIZED HOSPITALS
      • 8.2.2.1 Increasing demand for more specialized and advanced care to boost market
    • TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.2.3 SMALL HOSPITALS
      • 8.2.3.1 Need to decrease operational costs and growing competition to support adoption
    • TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 LONG-TERM CARE FACILITIES
    • TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.3.1 NURSING HOMES
      • 8.3.1.1 Growing geriatric population to favor end-user growth
    • TABLE 35 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.3.2 SKILLED NURSING FACILITIES
      • 8.3.2.1 Advancements in HCIT solutions to favor adoption in SNFs
    • TABLE 36 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION)
    • 8.3.3 ASSISTED LIVING FACILITIES
      • 8.3.3.1 ALFs to show significant growth alongside rising geriatric population
    • TABLE 37 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 38 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2020-2027)
    • TABLE 39 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
    • FIGURE 28 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
    • TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 42 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 43 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 44 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Advanced medical infrastructure and increasing healthcare expenditure to drive market growth
    • TABLE 47 US: KEY MACROINDICATORS
    • TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 49 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 51 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 52 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 53 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Rising adoption of advanced HCIT solutions to propel market growth
    • TABLE 54 CANADA: KEY MACROINDICATORS
    • TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 56 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 58 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 59 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 60 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
    • TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 63 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 64 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 65 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 66 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 67 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany to hold largest share of European market
    • TABLE 68 GERMANY: KEY MACROINDICATORS
    • TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 70 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 73 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 High healthcare spending and favorable government initiatives to drive market growth in France
    • TABLE 75 FRANCE: KEY MACROINDICATORS
    • TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 77 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 80 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK
    • TABLE 82 UK: KEY MACROINDICATORS
    • TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 84 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 85 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 87 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Increasing adoption of eHealth technologies to propel market growth in Italy
    • TABLE 89 ITALY: KEY MACROINDICATORS
    • TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 91 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 94 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Emphasis on infrastructural improvement and rising disease prevalence to contribute to growth
    • TABLE 96 SPAIN: KEY MACROINDICATORS
    • TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 98 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 101 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.7 SWITZERLAND
      • 9.3.7.1 Increasing demand for healthcare services and growing healthcare awareness to augment market
    • TABLE 103 SWITZERLAND: KEY MACROINDICATORS
    • TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 105 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 108 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.8 NETHERLANDS
      • 9.3.8.1 Increasing healthcare initiatives to favor demand growth
    • TABLE 110 NETHERLANDS: KEY MACROINDICATORS
    • TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 112 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 114 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 115 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.3.9 REST OF EUROPE
    • TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 118 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 121 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
    • FIGURE 29 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
    • TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Japan to dominate APAC market over forecast period
    • TABLE 130 JAPAN: KEY MACROINDICATORS
    • TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 132 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 135 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 Healthcare infrastructure improvements in China to contribute to market growth
    • TABLE 137 CHINA: KEY MACROINDICATORS
    • TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 139 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 142 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Increasing demand for HCIT solutions to support market growth
    • TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 145 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 148 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 149 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.5 AUSTRALIA AND NEW ZEALAND
      • 9.4.5.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ
    • TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 151 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 154 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 155 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Increasing medical tourism to boost market
    • TABLE 156 SOUTH KOREA: KEY MACROINDICATORS
    • TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 158 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 161 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 164 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 167 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 FAVORABLE HCIT INITIATIVES TO DRIVE MARKET GROWTH
    • 9.5.2 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
    • TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 170 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 173 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
    • 9.6.2 MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION
    • TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • TABLE 179 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
  • 10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS
  • 10.4 REVENUE SHARE ANALYSIS
    • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS
  • 10.5 MARKET SHARE ANALYSIS
    • FIGURE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET: MARKET SHARE ANALYSIS, 2021
  • 10.6 COMPETITIVE BENCHMARKING
    • TABLE 181 COMPANY FOOTPRINT ANALYSIS
    • TABLE 182 PRODUCT & SERVICE FOOTPRINT ANALYSIS (25 COMPANIES)
    • TABLE 183 END-USER FOOTPRINT ANALYSIS (25 COMPANIES)
    • TABLE 184 REGIONAL FOOTPRINT ANALYSIS (25 COMPANIES)
  • 10.7 COMPANY EVALUATION QUADRANT, 2021
    • 10.7.1 STARS
    • 10.7.2 PERVASIVE PLAYERS
    • 10.7.3 EMERGING LEADERS
    • 10.7.4 PARTICIPANTS
    • FIGURE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2021
  • 10.8 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
    • 10.8.1 PROGRESSIVE COMPANIES
    • 10.8.2 DYNAMIC COMPANIES
    • 10.8.3 RESPONSIVE COMPANIES
    • 10.8.4 STARTING BLOCKS
    • FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS
    • TABLE 185 INFECTION SURVEILLANCE SOLUTIONS MARKET: PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS, 2020-2022
    • 10.9.2 DEALS
    • TABLE 186 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEALS, 2020-2022
    • 10.9.3 OTHER DEVELOPMENTS
    • TABLE 187 INFECTION SURVEILLANCE SOLUTIONS MARKET: OTHER DEVELOPMENTS, 2020-2022

11 COMPANY PROFILES

(Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

  • 11.1 KEY PLAYERS
    • 11.1.1 BECTON, DICKINSON AND COMPANY
    • TABLE 188 BD: COMPANY OVERVIEW
    • FIGURE 34 BD: COMPANY SNAPSHOT, 2022
    • TABLE 189 BD: PRODUCTS & SERVICES OFFERED
    • TABLE 190 BD: PRODUCT LAUNCHES/ENHANCEMENTS
    • TABLE 191 BD: DEALS
    • 11.1.2 CERNER CORPORATION
    • TABLE 192 CERNER CORPORATION: COMPANY OVERVIEW
    • FIGURE 35 CERNER CORPORATION: COMPANY SNAPSHOT, 2021
    • TABLE 193 CERNER CORPORATION: PRODUCTS & SERVICES OFFERED
    • TABLE 194 CERNER CORPORATION: DEALS
    • 11.1.3 PREMIER, INC.
    • TABLE 195 PREMIER, INC.: COMPANY OVERVIEW
    • FIGURE 36 PREMIER, INC.: COMPANY SNAPSHOT, 2022
    • TABLE 196 PREMIER, INC.: PRODUCTS & SERVICES OFFERED
    • TABLE 197 PREMIER, INC.: PRODUCT LAUNCHES/ENHANCEMENTS
    • TABLE 198 PREMIER, INC.: DEALS
    • 11.1.4 BAXTER INTERNATIONAL INC.
    • TABLE 199 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW
    • FIGURE 37 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT, 2021
    • TABLE 200 BAXTER INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
    • 11.1.5 WOLTERS KLUWER N.V.
    • TABLE 201 WOLTERS KLUWER N.V.: COMPANY OVERVIEW
    • FIGURE 38 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT, 2021
    • TABLE 202 WOLTERS KLUWER N.V.: PRODUCTS & SERVICES OFFERED
    • TABLE 203 WOLTERS KLUWER N.V.: LAUNCHES/ENHANCEMENTS
    • TABLE 204 WOLTERS KLUWER N.V.: OTHERS
    • 11.1.6 MERATIVE
    • TABLE 205 MERATIVE: COMPANY OVERVIEW
    • TABLE 206 MERATIVE: PRODUCTS & SERVICES OFFERED
    • TABLE 207 MERATIVE: OTHERS
    • 11.1.7 ECOLAB
    • TABLE 208 ECOLAB: COMPANY OVERVIEW
    • FIGURE 39 ECOLAB: COMPANY SNAPSHOT, 2021
    • TABLE 209 ECOLAB: PRODUCTS & SERVICES OFFERED
    • TABLE 210 ECOLAB: PRODUCT LAUNCHES/ENHANCEMENTS
    • TABLE 211 ECOLAB: DEALS
    • TABLE 212 ECOLAB: OTHERS
    • 11.1.8 BIOMERIEUX SA
    • TABLE 213 BIOMERIEUX SA: COMPANY OVERVIEW
    • FIGURE 40 BIOMERIEUX SA: COMPANY SNAPSHOT, 2021
    • TABLE 214 BIOMERIEUX SA: PRODUCTS & SERIVCES OFFERED
    • TABLE 215 BIOMERIEUX SA: PRODUCT LAUNCHES/ENHANCEMENTS
    • TABLE 216 BIOMERIEUX SA: DEALS
    • 11.1.9 GOJO INDUSTRIES, INC.
    • TABLE 217 GOJO INDUSTRIES, INC.: COMPANY OVERVIEW
    • TABLE 218 GOJO INDUSTRIES, INC.: PRODUCTS & SERVICES OFFERED
    • TABLE 219 GOJO INDUSTRIES: PRODUCT LAUNCHES/ENHANCEMENTS
    • 11.1.10 RLDATIX
    • TABLE 220 RLDATIX: COMPANY OVERVIEW
    • TABLE 221 RLDATIX: PRODUCTS & SERVICES OFFERED
    • TABLE 222 RLDATIX: PRODUCT LAUNCHES/ENHANCEMENTS
    • TABLE 223 RLDATIX: DEALS
    • 11.1.11 VIGILANZ CORPORATION
    • TABLE 224 VIGILANZ CORPORATION: COMPANY OVERVIEW
    • TABLE 225 VIGILANZ CORPORATION: PRODUCTS & SERVICES OFFERED
    • TABLE 226 VIGILANZ CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS
    • 11.1.12 DEB GROUP LTD
    • TABLE 227 DEB GROUP LTD.: COMPANY OVERVIEW
    • TABLE 228 DEB GROUP LTD.: PRODUCTS & SERVICES OFFERED
    • 11.1.13 CLINISYS
    • TABLE 229 CLINISYS: COMPANY OVERVIEW
    • TABLE 230 CLINISYS: PRODUCTS & SERVICES OFFERED
    • TABLE 231 CLINISYS: DEALS
    • 11.1.14 BIOVIGIL HEALTHCARE SYSTEMS
    • TABLE 232 BIOVIGIL HEALTHCARE SYSTEMS: COMPANY OVERVIEW
    • TABLE 233 BIOVIGIL HEALTHCARE SYSTEMS: PRODUCTS & SERVICES OFFERED
    • TABLE 234 BIOVIGIL HEALTHCARE SYSTEMS: DEALS
    • 11.1.15 VECNA TECHNOLOGIES
    • TABLE 235 VECNA TECHNOLOGIES: COMPANY OVERVIEW
    • TABLE 236 VECNA TECHNOLOGIES: PRODUCTS & SERVICES OFFERED
    • 11.1.16 HARRIS HEALTHCARE
    • TABLE 237 HARRIS HEALTHCARE: COMPANY OVERVIEW
    • TABLE 238 HARRIS HEALTHCARE: PRODUCTS & SERVICES OFFERED
    • TABLE 239 HARRIS HEALTHCARE: DEALS
    • 11.1.17 PERAHEALTH
    • TABLE 240 PERAHEALTH: COMPANY OVERVIEW
    • TABLE 241 PERAHEALTH: PRODUCTS & SERVICES OFFERED
    • TABLE 242 PERAHEALTH: PRODUCT LAUNCHES/ENHANCEMENTS
    • TABLE 243 PERAHEALTH: DEALS
    • TABLE 244 PERAHEALTH: OTHERS
    • 11.1.18 MEDEXTER HEALTHCARE
    • TABLE 245 MEDEXTER HEALTHCARE: COMPANY OVERVIEW
    • TABLE 246 MEDEXTER HEALTHCARE: PRODUCTS & SERVICES OFFERED
    • TABLE 247 MEDEXTER HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS
    • 11.1.19 CENTRAK
    • TABLE 248 CENTRAK: COMPANY OVERVIEW
    • TABLE 249 CENTRAK: PRODUCTS & SERVICES OFFERED
    • TABLE 250 CENTRAK: PRODUCT LAUNCHES
    • TABLE 251 CENTRAK: DEALS
    • TABLE 252 CENTRAK: OTHERS
    • 11.1.20 CKM HEALTHCARE INCORPORATED
    • TABLE 253 CKM HEALTHCARE INCORPORATED: COMPANY OVERVIEW
    • TABLE 254 CKM HEALTHCARE INCORPORATED: PRODUCTS & SERVICES OFFERED
  • 11.2 OTHER PLAYERS
    • 11.2.1 ASOLVA INC.
    • 11.2.2 POINTCLICKCARE
    • 11.2.3 VITALACY INC.
    • 11.2.4 STANLEY HEALTHCARE
    • 11.2.5 VIZZIA TECHNOLOGIES
  • *Details on Business Overview, Products & services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS